Solid Historical Income Statement
| SLDB Stock | USD 5.51 0.48 8.01% |
Historical analysis of Solid Biosciences income statement accounts such as Other Operating Expenses of 81.3 M, Research Development of 60.6 M, Cost Of Revenue of 80.4 M or Total Operating Expenses of 25.3 M can show how well Solid Biosciences LLC performed in making a profits. Evaluating Solid Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Solid Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Solid Biosciences LLC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Solid Biosciences LLC is a good buy for the upcoming year.
Solid |
About Solid Income Statement Analysis
Solid Biosciences LLC Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Solid Biosciences shareholders. The income statement also shows Solid investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Solid Biosciences Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Solid Biosciences LLC. It is also known as Solid Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Solid Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Solid Biosciences LLC current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Solid Biosciences LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. At present, Solid Biosciences' Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 24.7 M, whereas Selling General Administrative is forecasted to decline to about 20.8 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 3.0M | 2.4M | 2.6M | 2.3M | Net Interest Income | 64K | 2.6M | 7.0M | 7.4M |
Solid Biosciences income statement Correlations
Click cells to compare fundamentals
Solid Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Solid Biosciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Income | 1.6M | 115K | 64K | 2.6M | 7.0M | 7.4M | |
| Selling General Administrative | 24.6M | 21.6M | 27.1M | 28.9M | 27.8M | 20.8M | |
| Gross Profit | (2.8M) | (3.9M) | (45.1M) | 5.7M | (76.6M) | (72.7M) | |
| Other Operating Expenses | 119.3M | 86.5M | 85.9M | 107.4M | 103.2M | 81.3M | |
| Operating Income | (119.3M) | (88.4M) | (72.3M) | (106.5M) | (104.3M) | (109.5M) | |
| Net Income From Continuing Ops | (117.2M) | (88.3M) | (72.2M) | (86.0M) | (90.8M) | (95.4M) | |
| Ebit | (119.3M) | (84.5M) | (72.3M) | (110.3M) | (104.3M) | (109.5M) | |
| Research Development | 94.7M | 64.9M | 58.7M | 78.4M | 76.6M | 60.6M | |
| Ebitda | (116.5M) | (80.6M) | (69.3M) | (107.9M) | (101.7M) | (106.8M) | |
| Cost Of Revenue | 2.8M | 3.9M | 58.7M | 2.4M | 76.6M | 80.4M | |
| Total Operating Expenses | 119.3M | 86.5M | 85.9M | 107.4M | 26.6M | 25.3M | |
| Income Before Tax | (117.2M) | (88.3M) | (72.2M) | (86.0M) | (96.0M) | (100.8M) | |
| Total Other Income Expense Net | 2.1M | 116K | 66K | 20.5M | 8.3M | 4.2M | |
| Net Income Applicable To Common Shares | (117.2M) | (88.3M) | (72.2M) | (86.0M) | (77.4M) | (81.3M) | |
| Net Income | (115.6M) | (90.1M) | (72.1M) | (65.5M) | (96.0M) | (100.8M) | |
| Income Tax Expense | (1.6M) | 1.8M | (64K) | (20.5M) | (18.4M) | (17.5M) | |
| Net Interest Income | 1.6M | 115K | 64K | 2.6M | 7.0M | 7.4M | |
| Depreciation And Amortization | 2.8M | 3.9M | 3.0M | 2.4M | 2.6M | 2.3M | |
| Reconciled Depreciation | 2.8M | 3.9M | 3.0M | 2.4M | 2.9M | 2.7M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Solid Biosciences LLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Solid Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Solid Biosciences Llc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Solid Biosciences Llc Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Solid Biosciences LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solid Biosciences. If investors know Solid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Solid Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.04) | Quarterly Revenue Growth (1.00) | Return On Assets (0.35) | Return On Equity (0.66) |
The market value of Solid Biosciences LLC is measured differently than its book value, which is the value of Solid that is recorded on the company's balance sheet. Investors also form their own opinion of Solid Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Solid Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Solid Biosciences' market value can be influenced by many factors that don't directly affect Solid Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Solid Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Solid Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Solid Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.